Novel fluorinated surfactants for perfluorochemical emulsification: biocompatibility assessments of glycosidic and polyol derivatives.
暂无分享,去创建一个
K. Lowe | C. Edwards | H. Trabelsi | A. Cambon | P. Lucas
[1] K. Lowe,et al. Effects of the co-polymer surfactant, Pluronic F-68, on platelet aggregation in human whole blood. , 1997, Artificial cells, blood substitutes, and immobilization biotechnology.
[2] K. Lowe,et al. Effects of pluronic F-68 (poloxamer 188) on platelet aggregation in human whole blood. , 1996, Thrombosis Research.
[3] J. Parrillo,et al. Reduction in Reperfusion‐Induced Myocardial Necrosis in Dogs by RheothRx Injection (Poloxamer 188 N.F.), a Hemorheological Agent That Alters Neutrophil Function , 1994, Circulation.
[4] K. Lowe. Perfluorochemicals in Vascular Medicine , 1994 .
[5] G. Biro. Perfluorocarbon-based red blood cell substitutes. , 1993, Transfusion medicine reviews.
[6] R. Vestal,et al. Impaired beta-adrenoceptor function, increased leukocyte respiratory burst, and bronchial hyperresponsiveness. , 1992, The Journal of allergy and clinical immunology.
[7] P. Vierling,et al. Synthesis and preliminary data on the biocompatibility and emulsifying properties of perfluoroalkylated phosphoramidates as injectable surfactants , 1991 .
[8] P. G. Barton.,et al. Effects of a polyoxyethylene detergent (Brij 58) on platelet aggregation, release and clotting activity. , 1978, Biochimica et biophysica acta.
[9] K. Lowe,et al. Haemolytic properties of pluronic surfactants and effects of purification. , 1995, Artificial cells, blood substitutes, and immobilization biotechnology.
[10] E. Kissa. Fluorinated surfactants : synthesis, properties, applications , 1994 .
[11] Zuck Tf,et al. Current status of injectable oxygen carriers. , 1994 .